Cours Abattis Bioceuticals Corp. Canadian Securities Exchange
Actions
ATT
CA00258G1037
Installations et services en soins de santé
CA 2018 | 8,37 k 6,1 k 5,59 k | CA 2019 | 357 k 260 k 238 k | Capitalisation | 8,62 M 6,28 M 5,75 M |
---|---|---|---|---|---|
Résultat net 2018 | -78 M -56,8 M -52,08 M | Résultat net 2019 | -3 M -2,18 M -2 M | VE / CA 2018 | 5 778 x |
Trésorerie nette 2018 | 9,1 M 6,62 M 6,07 M | Trésorerie nette 2019 | 2,25 M 1,64 M 1,5 M | VE / CA 2019 | 17,8 x |
PER 2018 |
-0,57
x | PER 2019 |
-2,8
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 99,64% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Director of Finance/CFO | - | 01/04/19 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 01/11/18 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 19/10/18 |
Patrick Mitchell
COO | Chief Operating Officer | - | 01/11/18 |
Director of Finance/CFO | - | 01/04/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+46,09% | 375 M | |
+30,93% | 313 M | |
+53,49% | 220 M | |
-28,99% | 183 M | |
+56,76% | 171 M | |
-28,57% | 144 M | |
+148,33% | 123 M | |
+3,85% | 106 M | |
+150,00% | 75,33 M |